ACRX | AcelRx Pharmaceuticals Inc
Category: Consumer goods
Industry: Drug Manufacturers - Major Quick infos Headquarters: Redwood City, California, United States Trade prices Volume: 13.0K Market Cap: 26.24M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: May 10, 2023 After Market Closes
Earnings History Date EPS / Forecast Revenue / Forecast May 10, 2023 -0.75 / -0.04252K / 5.35MBeat! March 9, 2023 - / -0.035- / 5.35MNovember 10, 2022 -0.94 / -1.20507.0K / 0.63MBeat! August 11, 2022 0.48 / -0.075570K / 550KBeat! May 16, 2022 -0.06 / -0.06442K / 550KBeat! view more
Historical Data Date Price Open High Low Vol Change ER May 8, 2023 0.74 0.66 0.75
0.63
126K 13.85% May 5, 2023 0.65 0.55 0.66
0.55
211K 4.84% May 4, 2023 0.62 0.63 0.66
0.6
70.0K -3.13% May 3, 2023 0.64 0.65 0.67
0.61
98.1K -3.03% May 2, 2023 0.66 0.64 0.68
0.58
139K 0% May 1, 2023 0.66 0.66 0.7
0.66
18.7K -1.49% Apr 28, 2023 0.67 0.67 0.7
0.66
55.1K -1.47% Apr 27, 2023 0.68 0.68 0.69
0.67
47.0K 0% Apr 26, 2023 0.68 0.68 0.7
0.67
43.7K 0% Apr 25, 2023 0.68 0.69 0.7
0.67
73.6K -1.45% view more
News
AcelRx Pharmaceuticals GAAP EPS of $1.00 beats by $1.51, revenue of $0.25M misses by $4.25M seekingalpha.com Mar 31, 2023 4:11 am AcelRx Pharmaceuticals Q4 2022 Earnings Preview seekingalpha.com Mar 30, 2023 2:10 am AcelRx adds 16% on plans to divest pain therapy seekingalpha.com Mar 14, 2023 9:20 pm AcelRx Pharmaceuticals GAAP EPS of -$0.94 beats by $0.26, revenue of $0.51M misses by $0.12M seekingalpha.com Nov 15, 2022 5:02 am AcelRx Pharmaceuticals Q3 2022 Earnings Preview seekingalpha.com Nov 12, 2022 6:35 am AcelRx announces 1-for-20 reverse stock split, shares drop 15% aftermarket seekingalpha.com Oct 26, 2022 4:52 am AcelRx announces $7.5M direct offering of common stock and warrants seekingalpha.com Dec 27, 2022 10:15 pm AcelRx Pharma rises8% on positive data from post-operative pain management therapy seekingalpha.com Dec 8, 2022 10:19 pm AcelRx Pharma stock falls ~17% premarket after Q2 results, large runup in shares seekingalpha.com Aug 12, 2022 9:28 pm AcelRx PharmaceuticalsEPS of $0.48, revenue of $0.57M beats by $0.02M seekingalpha.com Aug 12, 2022 4:02 am AcelRx Pharmaceuticals Q2 2022 Earnings Preview seekingalpha.com Aug 11, 2022 5:35 am Inovio Pharma, Bionano Genomics among health care stocks to join Russell Microcap Index; Tonix Pharma, iBio to leave seekingalpha.com Jun 6, 2022 11:59 pm FDA reduces certain requirements under drug safety program for AcelRx's Dsuvia seekingalpha.com May 19, 2022 10:24 pm AcelRx Pharmaceuticals GAAP EPS of -$0.06 in-line, revenue of $0.44M misses by $0.11M seekingalpha.com May 16, 2022 7:33 pm AcelRx' sufentanil sublingual tablet reduces postoperative opioid requirement seekingalpha.com May 10, 2022 11:05 pm AcelRx stock falls 15% after HC Wainwright downgrade on 'disappointing quarter' seekingalpha.com Mar 15, 2022 12:02 am AcelRx stock falls 18% following Q4 results seekingalpha.com Mar 11, 2022 11:38 pm AcelRx Pharmaceuticals GAAP EPS of -$0.06 beats by $0.01, revenue of $0.2M misses by $1.65M seekingalpha.com Mar 11, 2022 5:08 am AcelRx Pharmaceuticals Q4 2021 Earnings Preview seekingalpha.com Mar 10, 2022 6:35 am AcelRx announces data on pain drug sufentanil sublingual for use in awake plastic surgery seekingalpha.com Feb 2, 2022 4:39 am Talk about AcelRx Pharmaceuticals Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.